Ahn Bokyung, Kim Deokhoon, Kim Mi-Ju, Jeong Seo-Rin, Song In Hye, Kim Joo Young, Hong Soon Auck, Jun Sun-Young, Cho HyungJun, Park Young Soo, Escorcia Freddy E, Chung Joon-Yong, Hong Seung-Mo
Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Biomedical Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.
Gastric Cancer. 2025 Jan;28(1):27-40. doi: 10.1007/s10120-024-01557-8. Epub 2024 Oct 1.
Gastric neuroendocrine carcinomas (NECs) are rare cancers with highly aggressive behavior. Although tertiary lymphoid structures (TLSs) are well-known prognostic factors in various cancers, their role in gastric NECs remain unexplored. Unique immunohistochemical subtypes of pulmonary NECs have been discovered, however, their feasibility in gastric NECs is unknown.
The presence and maturation of TLSs (lymphoid aggregates, primary and secondary follicles) were assessed in 48 surgically resected gastric NECs and were compared with immunohistochemical subtypes, using a panel of ASCL1, NeuroD1, POU2F3, YAP1, and DLL3 with three neuroendocrine (NE) markers.
Patients with secondary follicles had significantly better overall survival (OS) and recurrence-free survival (RFS; both, p = 0.004) than those without them. Based on the hierarchical clustering, gastric NECs were classified into all low/negative (31%), high-YAP1 (19%), high-DLL3/low-NE (29%), and high-NE (21%) expression groups. The high-DLL3/low-NE group was associated with absent TLSs (p = 0.026) and showed the worst OS (p = 0.026). Distant metastasis and a lack of secondary follicles were poor independent prognostic factors of OS and RFS.
The assessment of TLSs is a feasible and potent biomarker for gastric NECs, thus enabling better prognosis and more effective immunotherapy. Furthermore, gastric NECs can be categorized as four immunohistochemically distinct groups, of which the high-DLL3/low-NE group has the worst OS with lack of TLSs.
胃神经内分泌癌(NEC)是具有高度侵袭性的罕见癌症。尽管三级淋巴结构(TLS)是各种癌症中众所周知的预后因素,但其在胃NEC中的作用仍未得到探索。独特的肺NEC免疫组织化学亚型已被发现,然而,其在胃NEC中的可行性尚不清楚。
在48例手术切除的胃NEC中评估TLS(淋巴聚集、初级和次级滤泡)的存在和成熟情况,并与免疫组织化学亚型进行比较,使用一组ASCL1、NeuroD1、POU2F3、YAP1和DLL3以及三种神经内分泌(NE)标志物。
有次级滤泡的患者总生存期(OS)和无复发生存期(RFS;两者p = 0.004)明显优于没有次级滤泡的患者。基于层次聚类,胃NEC被分为所有低表达/阴性(31%)、高YAP1(19%)、高DLL3/低NE(29%)和高NE(21%)表达组。高DLL3/低NE组与TLS缺失相关(p = 0.026),且OS最差(p = 0.026)。远处转移和缺乏次级滤泡是OS和RFS的不良独立预后因素。
TLS评估是胃NEC可行且有效的生物标志物,从而能够实现更好的预后和更有效的免疫治疗。此外,胃NEC可分为四个免疫组织化学不同的组,其中高DLL3/低NE组OS最差且缺乏TLS。